MedPath
FDA Product

Propafenone Hydrochloride

Product approved by U.S. Food and Drug Administration (US)

Basic Information

Propafenone Hydrochloride

51407-477

Regulatory Information

51407-477

ANDA212928

C73584

January 8, 2024

USA

PROPAFENONE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES. These highlights do not include all the information needed to use PROPAFENONE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for PROPAFENONE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES. PROPAFENONE HYDROCHLORIDE extended-release capsules, for oral use Initial U.S. Approval: 1989

HUMAN PRESCRIPTION DRUG LABEL

3

Company Information

603184490

Active Ingredients

HYPROMELLOSE 2910 (3 MPA.S)

Code: 0VUT3PMY82

Class Code: IACT

MAGNESIUM STEARATE

Code: 70097M6I30

Class Code: IACT

GELATIN, UNSPECIFIED

Code: 2G86QN327L

Class Code: IACT

SODIUM LAURYL SULFATE

Code: 368GB5141J

Class Code: IACT

TITANIUM DIOXIDE

Code: 15FIX9V2JP

Class Code: IACT

SHELLAC

Code: 46N107B71O

Class Code: IACT

PROPYLENE GLYCOL

Code: 6DC9Q167V3

Class Code: IACT

FERRIC OXIDE RED

Code: 1K09F3G675

Class Code: IACT

POTASSIUM HYDROXIDE

Code: WZH3C48M4T

Class Code: IACT

AMMONIA

Code: 5138Q19F1X

Class Code: IACT

PROPAFENONE HYDROCHLORIDE

Quantity: 225 mg in 1 1

Code: 33XCH0HOCD

Class Code: ACTIB

Active Moieties

PROPAFENONE

Code: 68IQX3T69U

© Copyright 2025. All Rights Reserved by MedPath